Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19888132 | 0.91 | HTT (0.46) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL12440932 | 0.91 | HPGD (0.43) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL24416475 | 0.89 | MEN1 (0.52) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL19888134 | 0.87 | HTT (0.43) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL15025823 | 0.87 | POLB (0.44) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL18947669 | 0.86 | ACHE (0.48) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL18390943 | 0.85 | MEN1 (0.55) | HTTHPGDMAPTPKMALOX15 | |
| SCHEMBL9913062 | 0.85 | POLB (0.46) | HTTHPGDMAPTALOX15TSHR | |
| SCHEMBL23382045 | 0.83 | KDM4E (0.53) | HTTHPGDMAPTMAPK1HSD17B10 | |
| SCHEMBL13241210 | 0.82 | MAPT (0.50) | HTTHPGDMAPTPKMALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3345983-A1 | COMPOUNDS CONTAINING AT LEAST ONE DISILYL COMPOUND SELECTED FROM DISILYLCARBAZOLES, DISILYLDIBENZOFURANS, DISILYLDIBENZOTHIOPHENES, DISILYLDIBENZOPHOSPHOLES, DISILYLDIBENZOTHIOPHENE S-OXIDES AND DISILYLDIBENZOTHIOPHENE S, S-DIOXIDES | UDC Ireland Limited (IE) | 2018-07-11 | — | — | EP | disclosed |
| US-9676906-B1 | Polymer of poly(arylene ether)s, manufacturing method thereof and polymer light emitting diode with organic light emitting layer made from the same | NATIONAL SUN YAT-SEN UNIVERSITY (TW) | 2017-06-13 | — | — | US | disclosed |
| US-8900725-B2 | Dendrimer and organic light-emitting device using the same | SAMSUNG DISPLAY CO., LTD. | 2014-12-02 | — | — | US | disclosed |
| US-8859172-B2 | Electrophotographic photosensitive member, method of producing electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2014-10-14 | — | — | US | disclosed |
| US-20130137021-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, METHOD OF PRODUCING ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2013-05-30 | — | — | US | disclosed |
| CN-101884122-B | Use of diphenylamino-bis (phenoxy) triazines and bis (diphenylamino) phenoxytriazine compounds | BASF SE | 2012-06-06 | — | — | CN | disclosed |
| US-20120013246-A1 | DENDRIMER AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-01-19 | — | — | US | disclosed |
| CN-101884122-A | Use of diphenylamino-bis (phenoxy) triazines and bis (diphenylamino) phenoxytriazine compounds | BASF SE | 2010-11-10 | — | — | CN | disclosed |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-10-14 | — | — | US | disclosed |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-10-14 | — | — | US | disclosed |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-10-14 | — | — | US | disclosed |
| EP-2206175-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009053346-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2009-04-30 | — | — | WO | disclosed |
| WO-2009053346-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2009-04-30 | — | — | WO | disclosed |
| US-20080054794-A1 | Organic Electroluminescence Device, Image Display Apparatus and Lighting Apparatus Including the Same, Charge Transport Material and Charge Transport Layer Forming Ink Including the Same | Fujiki, Michiya (JP) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120013246-A1 | DENDRIMER AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | CLTB, CD40LG, DYNLL2 | HTT 4099/4885HPGD 3620/4885MAPT 446/4885 |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | TRPC6, KCNB1, CACNA1I | HTT 151/4885HPGD 3007/4885MAPT 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.